Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GMAB · against 78 other Healthcare companies of similar size
Ranked #52 of 79 · scores higher than 35% of peers · safety percentile 25
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)17 peers with a safety percentile of 20–29, including GMAB · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GMAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 76 reported | 0.89× | 0.48× | 19% | 33% | |
| BetaLower is better · 76 reported | 0.70 | 0.76 | 56% | 33% | |
| Current ratioHigher is better · 75 reported | 2.46× | 1.80× | 66% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 26.0B USD | 93 | 28 | |
| 2 | 327.3B CNY (≈$45.8B) | 92 | 75 | |
| 3 | 56.7B USD | 85 | 79 | |
| 4 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 5 | 25.8B USD | 83 | 75 | |
| 48 | 27.5B EUR (≈$30.2B) | 27 | 60 | |
| 49 | 18.5B USD | 26 | 62 | |
| 50 | 28.7B USD | 26 | 52 | |
| 51 | 50.2B USD | 25 | 49 | |
| 52 | 34.6B USD | 25 | 58 | |
| 53 | 49.5B USD | 24 | 53 | |
| 54 | 95.4B AUD (≈$62.9B) | 24 | 48 | |
| 55 | 154.4B BRL (≈$27.8B) | 23 | 43 | |
| 56 | 133.4B BRL (≈$24.0B) | 23 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score